Management & Regulatory

Swedish Startup Ironic Biotech Raises €1M for Iron-Rich Plant Foods
Management & Regulatory Swedish Startup Ironic Biotech Raises €1M for Iron-Rich Plant Foods

Swedish newcomer Ironic Biotech has just placed itself at the forefront of the dietary supplement market by securing a hefty €1 million in pre-seed funding. Their breakthrough in developing heme iron from plant sources could drastically alter how we combat iron deficiencies worldwide. As the global

Is Biotech the Next Big Boom? Incyte, Jazz, Exelixis Lead
Management & Regulatory Is Biotech the Next Big Boom? Incyte, Jazz, Exelixis Lead

The Biotech Industry Landscape Biotech Innovation and Market Growth The biotech sector is experiencing a remarkable surge, propelled by advances in personalized medicine and increased interest in orphan drugs. Personalized medicine is a game-changer, allowing treatments to be specifically tailored

Biomanufacturing's Third Wave: Navigating New Complexities
Management & Regulatory Biomanufacturing's Third Wave: Navigating New Complexities

At the recent BPI Europe 2024 conference, a landmark discussion led by Uwe Buecheler from Boehringer Ingelheim marked the dawn of a new chapter in biopharmaceuticals. Described as the 'third wave' of biologics, it signifies an era brimming with groundbreaking therapeutic innovations that stand to

NIIMBL Invests $10M in Biopharma Manufacturing and Workforce Growth
Management & Regulatory NIIMBL Invests $10M in Biopharma Manufacturing and Workforce Growth

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is heralding a new era in biopharmaceutical production with a significant investment that aims to spur innovation and streamline processes in this critical industry. In its latest move, NIIMBL has dedicated $10

Revolutionizing Pharma: AI's Role in Slashing Drug Manufacturing Costs
Management & Regulatory Revolutionizing Pharma: AI's Role in Slashing Drug Manufacturing Costs

The biopharmaceutical industry is undergoing a radical transformation as digital tools, particularly artificial intelligence (AI) and machine learning (ML), are increasingly deployed to tackle the daunting challenge of reducing drug manufacturing costs. These technologies are not just incremental

Data-Blind SaaS: Redefining Privacy in Cloud Computing
Management & Regulatory Data-Blind SaaS: Redefining Privacy in Cloud Computing

The digital ecosystem is witnessing a paradigm shift with the introduction of 'data-blind SaaS', a futuristic model poised to overhaul the traditional norms of cloud computing. For years, Software as a Service (SaaS) models have been the linchpin of cloud-based business operations, enabling

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later